메뉴 건너뛰기




Volumn 31, Issue 8, 2013, Pages 1251-1254

Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; WARFARIN;

EID: 84881188010     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2013.05.008     Document Type: Article
Times cited : (22)

References (25)
  • 1
    • 44649185707 scopus 로고    scopus 로고
    • Warfarin-induced bleeding complications- clinical presentation and therapeutic options
    • C.J. Wiedermann, and I. Stockner Warfarin-induced bleeding complications- clinical presentation and therapeutic options Thromb Res 122 Suppl. 2 2008 S13 S18
    • (2008) Thromb Res , vol.122 , Issue.SUPPL. 2
    • Wiedermann, C.J.1    Stockner, I.2
  • 2
    • 8444221659 scopus 로고    scopus 로고
    • Warfarin reversal
    • J.P. Hanley Warfarin reversal J Clin Pathol 57 2004 1132 1139
    • (2004) J Clin Pathol , vol.57 , pp. 1132-1139
    • Hanley, J.P.1
  • 3
    • 84856784474 scopus 로고    scopus 로고
    • Antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition)
    • W. Ageno, A.S. Gallus, and A. Wittkowsky Antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition) Chest 141 2012 44s 88s
    • (2012) Chest , vol.141
    • Ageno, W.1    Gallus, A.S.2    Wittkowsky, A.3
  • 4
    • 84859944372 scopus 로고    scopus 로고
    • Blood component support in acquired coagulopathic conditions: Is there a method to the madness?
    • T.N. Pandit, and R. Sarode Blood component support in acquired coagulopathic conditions: is there a method to the madness? Am J Hematol 87 Suppl. 1 2012 S56 S62
    • (2012) Am J Hematol , vol.87 , Issue.SUPPL. 1
    • Pandit, T.N.1    Sarode, R.2
  • 5
    • 61949237566 scopus 로고    scopus 로고
    • Transfusion-related acute lung injury: Current concepts for the clinician
    • D. Triulzi Transfusion-related acute lung injury: current concepts for the clinician Anesth Analg 108 2009 770 776
    • (2009) Anesth Analg , vol.108 , pp. 770-776
    • Triulzi, D.1
  • 6
    • 77954403042 scopus 로고    scopus 로고
    • Prothombin complex concentrates: An update
    • M. Franchini, and G. Lippi Prothombin complex concentrates: an update Blood Transfus 8 2010 149 154
    • (2010) Blood Transfus , vol.8 , pp. 149-154
    • Franchini, M.1    Lippi, G.2
  • 7
    • 33749828691 scopus 로고    scopus 로고
    • Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage
    • M.W. Russell, A.V. Joshi, and P.J. Neumann Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage Neurology 67 7 2006 1279 1281
    • (2006) Neurology , vol.67 , Issue.7 , pp. 1279-1281
    • Russell, M.W.1    Joshi, A.V.2    Neumann, P.J.3
  • 8
    • 79960789659 scopus 로고    scopus 로고
    • Prothrombin complex concentrate for critical bleeding
    • A. Patanwala, N. Acquisto, and B. Erstad Prothrombin complex concentrate for critical bleeding Ann Pharmacother 45 2011 990 999
    • (2011) Ann Pharmacother , vol.45 , pp. 990-999
    • Patanwala, A.1    Acquisto, N.2    Erstad, B.3
  • 9
    • 66549108216 scopus 로고    scopus 로고
    • Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose
    • L. Holland, T. Warkentin, and M. Refaai Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Transfusion 49 2009 1171 1177
    • (2009) Transfusion , vol.49 , pp. 1171-1177
    • Holland, L.1    Warkentin, T.2    Refaai, M.3
  • 10
    • 84865595832 scopus 로고    scopus 로고
    • Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage
    • 00-00
    • J. Switzer, J. Rocker, and P. Mohorn Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage Stroke 43 2012 00-00
    • (2012) Stroke , vol.43
    • Switzer, J.1    Rocker, J.2    Mohorn, P.3
  • 11
    • 84857822338 scopus 로고    scopus 로고
    • Rapid warfarin reversal: A 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage
    • R. Sarode, K. Matevosyan, and R. Bhagat Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage J Neurosurg 116 3 2012 491 497
    • (2012) J Neurosurg , vol.116 , Issue.3 , pp. 491-497
    • Sarode, R.1    Matevosyan, K.2    Bhagat, R.3
  • 12
    • 0036826024 scopus 로고    scopus 로고
    • Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication
    • M. Yasaka, T. Sakata, and K. Minematsu Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication Thromb Res 108 2002 25 30
    • (2002) Thromb Res , vol.108 , pp. 25-30
    • Yasaka, M.1    Sakata, T.2    Minematsu, K.3
  • 13
    • 73549085173 scopus 로고    scopus 로고
    • Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
    • W. Wójcik, M. Schymik, and E. Cure Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy Int J Emerg Med 2 2009 217 225
    • (2009) Int J Emerg Med , vol.2 , pp. 217-225
    • Wójcik, W.1    Schymik, M.2    Cure, E.3
  • 14
    • 47649108640 scopus 로고    scopus 로고
    • Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma
    • T. Livnat, U. Martinowitz, and A. Zivelin Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma Haemophilia 14 2008 782 786
    • (2008) Haemophilia , vol.14 , pp. 782-786
    • Livnat, T.1    Martinowitz, U.2    Zivelin, A.3
  • 15
    • 13244262642 scopus 로고    scopus 로고
    • Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity
    • L. Aledort Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity J Thromb Haemost 2 2004 1700 1708
    • (2004) J Thromb Haemost , vol.2 , pp. 1700-1708
    • Aledort, L.1
  • 16
    • 38349096220 scopus 로고    scopus 로고
    • Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature
    • C. Leissinger, P. Blatt, W. Hoots, and B. Ewenstein Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature Am J Hematol 83 2007 137 143
    • (2007) Am J Hematol , vol.83 , pp. 137-143
    • Leissinger, C.1    Blatt, P.2    Hoots, W.3    Ewenstein, B.4
  • 17
    • 79953699396 scopus 로고    scopus 로고
    • Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?
    • M. Makris, and J. van Veen Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? Blood Transfus 9 2011 117 119
    • (2011) Blood Transfus , vol.9 , pp. 117-119
    • Makris, M.1    Van Veen, J.2
  • 18
    • 84855671155 scopus 로고    scopus 로고
    • Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal
    • J. Baggs, A. Patanwala, E. Williams, and B. Erstad Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal Ann Pharmacother 46 2012 51 56
    • (2012) Ann Pharmacother , vol.46 , pp. 51-56
    • Baggs, J.1    Patanwala, A.2    Williams, E.3    Erstad, B.4
  • 19
    • 79953680507 scopus 로고    scopus 로고
    • Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial hemorrhage
    • D. Imberti, G. Barillari, and C. Biasioli Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial hemorrhage Blood Transfus 9 2011 148 155
    • (2011) Blood Transfus , vol.9 , pp. 148-155
    • Imberti, D.1    Barillari, G.2    Biasioli, C.3
  • 20
    • 52449128017 scopus 로고    scopus 로고
    • Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: Experience in a large tertiary hospital
    • D. Bruce, and T. Nokes Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital Crit Care 12 2008 R105
    • (2008) Crit Care , vol.12 , pp. 105
    • Bruce, D.1    Nokes, T.2
  • 21
    • 35648991453 scopus 로고    scopus 로고
    • Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation
    • H. Riess, A. Meier-Hellmann, and J. Motsch Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation Thromb Res 121 1 2007 9 16
    • (2007) Thromb Res , vol.121 , Issue.1 , pp. 9-16
    • Riess, H.1    Meier-Hellmann, A.2    Motsch, J.3
  • 22
    • 41349106674 scopus 로고    scopus 로고
    • Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation
    • K. Tanaka, F. Szlam, and G. Dickneite Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation Thromb Res 122 1 2008 117 123
    • (2008) Thromb Res , vol.122 , Issue.1 , pp. 117-123
    • Tanaka, K.1    Szlam, F.2    Dickneite, G.3
  • 23
    • 11044228152 scopus 로고    scopus 로고
    • FEIBA safety profile in multiple modes of clinical and home-therapy application
    • H. Luu, and B. Ewenstein FEIBA safety profile in multiple modes of clinical and home-therapy application Haemophilia 10 Suppl. 2 2004 10 16
    • (2004) Haemophilia , vol.10 , Issue.SUPPL. 2 , pp. 10-16
    • Luu, H.1    Ewenstein, B.2
  • 24
    • 0344131428 scopus 로고    scopus 로고
    • Thrombogenicity of prothrombin complex concentrates
    • M. Kohler Thrombogenicity of prothrombin complex concentrates Thromb Res 95 Suppl. 1 1999 S13 S17
    • (1999) Thromb Res , vol.95 , Issue.SUPPL. 1
    • Kohler, M.1
  • 25
    • 0034525056 scopus 로고    scopus 로고
    • Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity
    • J. Hoffer, B. Schwinn, and F. Biesert Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity Thromb Res 100 5 2000 433 441
    • (2000) Thromb Res , vol.100 , Issue.5 , pp. 433-441
    • Hoffer, J.1    Schwinn, B.2    Biesert, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.